Elevated expression of neuroinflammatory factors in the central nervous system (CNS) contributes to the cognitive impairment in CNS disorders such as injury, disease and neurodegenerative disorders. However, information on the role of specific neuroimmune factors in normal and abnormal CNS function is limited. In this study, we investigated the effects of chronic exposure to the chemokine CCL2 on hippocampal synaptic function at the Schaffer collateral-CA1 synapse, a synapse that is known to play an important role in cognitive functions such as memory and learning. Synaptic function was measured in vitro using hippocampal slices obtained from transgenic mice that express elevated levels of CCL2 in the CNS through astrocyte expression and their non-transgenic littermate controls. Extracellular field potential electrophysiological recordings showed a significant reduction in the magnitude of synaptic responses in hippocampal slices from the CCL2 transgenic mice compared with slices from non-transgenic littermate controls. Two forms of short-term synaptic plasticity (post-tetanic potentiation and short-term potentiation) thought to be important cellular mechanisms of short-term memory were enhanced in hippocampal slices from CCL2 transgenic mice compared to non-transgenic hippocampal slices, whereas long-term synaptic plasticity (LTP), which is critical to long-term memory formation, was not altered. Western blot analysis of hippocampus from the CCL2 transgenic mice and non-transgenic mice showed no change in level of neuronal specific enolase, a neuronal specific protein, GFAP, an astrocyte specific protein, and several synaptic proteins compared with non-transgenic littermate controls. These results show that CCL2, which is known to be chronically produced at elevated levels within the CNS in a number of CNS disorders, can significantly alter hippocampal function and implicate a role for CCL2 in the cognitive dysfunction associated with these CNS disorders.
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Introduction
It is now recognized that chemokines, a group of small signaling proteins that are members of the cytokine family of inflammatory factors, are produced within the CNS and can play an important role in normal CNS function and development as well as in CNS disease and injury (Cartier et al., 2005; Ubogu et al., 2006) . The primary CNS cell types that produce chemokines are astrocytes and microglia, although neurons also produce chemokines under some conditions (Flugel et al., 2001; Rock et al., 2004) . Chemokines are classified into four basic subfamilies, primarily based on the position of specific conserved cysteine residues in the N-terminal structure: a-(or CXC) chemokines, b-(or CC) chemokines (e.g., CCL2), c-(or C) chemokines and d-(or CX 3 C) (Murphy et al., 2000) . Our studies focus on the b-chemokine CCL2 (CC chemokine ligand 2, previously known as monocyte chemoattractant protein-1 or MCP-1), a small secreted protein.
Chemokines were first described in the immune system where they play a role in host immune surveillance, directing leukocyte traffic to sites of inflammation or injury, a role that they also play in the CNS (Miller et al., 2008) . Additional roles for chemokines as signaling molecules in the CNS are now emerging, although information is still limited. For example, recent studies show a physiological role for CXCL12 in CNS development. In these studies, selective deletion of either CXCL12 (SDF-1) or its receptor CXCR4, which have a monogamous interaction, disrupts the normal migration of cerebellar granule neurons and leads to abnormal formation of the cerebellum (Ma et al., 1998; Tran and Miller, 2003; Zhu et al., 2002) . The CXCR4 deficient mice show numerous deficiencies (Ma et al., 1998) . A similar role for CXCL12/CXCR4 was demonstrated for the migratory process occurring during morphogenesis of the dentate gyrus of the hippocampus (Lu et al., 2002) . Evidence for a role of CXCL12 in memory function has also appeared. Thus, in 0889-1591/$ -see front matter Ó 2011 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2011.02.013
